Khona Scientific Is Turning Baker's Yeast Into a Tiny Pharmaceutical Supply Chain

Khona began with rare cannabinoids and a stubborn biological problem: long pathways leak value at every step. Now the four-person Colorado biotech is aiming its microbial assembly line at a larger prize - domestic supplies of pharmaceutical starting materials and APIs.